Literature DB >> 8463330

Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor.

M Murgia1, S Hanau, P Pizzo, M Rippa, F Di Virgilio.   

Abstract

The effects of oxidized ATP (oATP) on responses triggered by extracellular adenosine 5'-triphosphate (ATPe) were investigated in the mouse macrophage-like cell line J774. ATPe induced in this cell line two kinds of responses mediated by two different P2 purinergic receptors: 1) an early permeabilization of the plasma membrane to extracellular hydrophilic markers of M(r) up to 900 mediated by P2Z receptors; and 2) a fast mobilization of Ca2+ from intracellular stores mediated by P2Y receptors. Low oATP concentrations (100 microM) completely blocked the first response without affecting the second. ATPe-dependent cell swelling, vacuolization, and lysis were also inhibited. Antagonism developed slowly, as an incubation at 37 degrees C for at least 2 h in the presence of oATP was needed and was irreversible, thus suggesting that the inhibitory action was due to covalent modification of the receptor. The rate of hydrolysis of exogenous ATP was slightly decreased by oATP, indicating a minor blocking effect of this compound on plasma membrane ecto-ATPases in the concentration range tested. These observations suggest that oATP may be a potentially very useful tool for isolation and characterization of the P2Z purinergic receptor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8463330

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  105 in total

1.  ATP-induced Ca2+ response mediated by P2U and P2Y purinoceptors in human macrophages: signalling from dying cells to macrophages.

Authors:  Y Oshimi; S Miyazaki; S Oda
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

2.  ATP-induced [Ca(2+)](i) changes and depolarization in GH3 cells.

Authors:  H S Chung; K S Park; S K Cha; I D Kong; J W Lee
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

3.  P2X7 receptors in Müller glial cells from the human retina.

Authors:  T Pannicke; W Fischer; B Biedermann; H Schädlich; J Grosche; F Faude; P Wiedemann; C Allgaier; P Illes; G Burnstock; A Reichenbach
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

4.  P2X7 receptor-pannexin 1 hemichannel association: effect of extracellular calcium on membrane permeabilization.

Authors:  V Poornima; M Madhupriya; S Kootar; G Sujatha; Arvind Kumar; Amal Kanti Bera
Journal:  J Mol Neurosci       Date:  2011-09-20       Impact factor: 3.444

5.  Synergic effects of mycoplasmal lipopeptides and extracellular ATP on activation of macrophages.

Authors:  Takeshi Into; Mari Fujita; Tsugumi Okusawa; Akira Hasebe; Manabu Morita; Ken-Ichiro Shibata
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

6.  ATP: a vasoactive signal in the pericyte-containing microvasculature of the rat retina.

Authors:  Hajime Kawamura; Tetsuya Sugiyama; David M Wu; Masato Kobayashi; Shigeki Yamanishi; Kozo Katsumura; Donald G Puro
Journal:  J Physiol       Date:  2003-07-22       Impact factor: 5.182

7.  Cell-autonomous regulation of hematopoietic stem cell cycling activity by ATP.

Authors:  A Casati; M Frascoli; E Traggiai; M Proietti; U Schenk; F Grassi
Journal:  Cell Death Differ       Date:  2010-08-27       Impact factor: 15.828

8.  Novel P2X7 receptor antagonists ease the pain.

Authors:  B F King
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

Review 9.  Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states.

Authors:  D L Donnelly-Roberts; M F Jarvis
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

10.  Nonselective cationic currents elicited by extracellular ATP in human B-lymphocytes.

Authors:  F Bretschneider; M Klapperstück; M Löhn; F Markwardt
Journal:  Pflugers Arch       Date:  1995-03       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.